Ischemia/reperfusion injury of skeletal muscle: Plasma taurine as a measure of tissue damage

Surgery

Volumn 133, Issue 1, 2003, Pages 91-100

  Nanobashvili, Joseph ^a,b   Neumayer, Christoph ^a,b   Fügl, Alexander ^a,b   Punz, Andreas ^a,b   Blumer, Roland ^a,b   Prager, Manfred ^a,b   Mittlböck, Martina ^a,b   Gruber, Helmut ^a,b   Polterauer, Peter ^a,b   Roth, Erich ^a,b   Malinski, Tadeusz ^a,b   Huk, Ihor ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; OXYGEN RADICAL; TAU PROTEIN; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; EDEMA; HINDLIMB; LIMB ISCHEMIA; LIPID PEROXIDATION; MALE; MEMBRANE RUPTURE; MUSCLE BIOPSY; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE ISCHEMIA; MUSCLE TETANIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RABBIT; SKELETAL MUSCLE; TISSUE INJURY; VASOCONSTRICTION;

EID: 0037263595     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.65     Document Type: Article

References (35)

1. Nanobashvili J, Neumayer C, Fuegl A, Sporn E, Prager M, Polterauer P, et al. Ischemia/reperfusion injury of skeletal muscle: mechanisms, morphology, treatment strategies, and clinical applications. European Surgery 2002;34:83-9.
2. Huk I, Brovkovych V, Nanobashvili J, Weigel G, Neumayer C, Partyka L, et al. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surg 1998;85:1080-5.
3. -) after ischaemia and reperfusion. J Surg Res 1991;50:565-8.
4. 1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release. Shock 2000;14:234-42.
5. Idström JP, Soussi B, Elander A, Bylund-Fellenius AC. Purine metabolism after in vivo ischemia and reperfusion in rat skeletal muscle. Am J Physiol Heart Circ Physiol 1990;258:H1668-73.
6. Roth E, Manhart N, Punz A. Antioxidative abwehrmechanismen während systemischer inflammation. Intensivmed 1998;35:95-105.
7. Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, et al. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997;96:667-75.
8. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.
9. Hernández-Maldonado JJ, Teehan E, Franco CD, Durán WN, Hobson RW. Superoxide anion production by leukocytes exposed to post-ischemic skeletal muscle. J Cardiovasc Surg (Torino) 1992;33:695-9.
10. Turner O, Phoenix J, Wray S. Developmental and gestational changes of phospho-ethanolamine and taurine in rat brain, striated and smooth muscle. Exp Physiol 1994;79:681-9.
11. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992;72:101-63.
12. Roth E, Zöch G, Schulz F, Karner J, Mühlbacher F, Hamilton G, et al. Amino acid concentrations in plasma and skeletal muscle of patients with acute hemorrhagic necrotizing pancreatitis. Clin Chem 1985;31:1305-9.
13. Suleiman MS, Fernando HC, Dihmis WC, Hutter JA, Chapman RA. A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery. Br Heart J 1993;69:241-5.
14. Lombardini JB, Cooper MW. Elevated blood taurine levels in acute and evolving myocardial infarction. J Lab Clin Med 1981;98:849-59.
15. Kennergren C, Mantovani V, Lonnroth P, Nystrom B, Berglin E, Hamberger A. Extracellular amino acids as markers of myocardial ischemia during cardioplegic heart arrest. Cardiology 1999;91:31-40.
16. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehydethiobarbituric acid adduct. Clin Chem 1987;33:214-20.
17. Wright CE, Tallan HH, Lin YY, Gaull GE. Taurine: biological update. Annu Rev Biochem 1986;55:427-53.
18. Koller R, Rab M, Todoroff BP, Neumayer Ch, Haslik W, Stöhr HG, et al. The influence of the graft length on the functional and morphological results after nerve grafting: an experimental study in rabbits. Br J Plast Surg 1997;50:609-14.
19. Huxtable RJ. Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 1989;32:471-533.
20. Gaull GE. Taurine as a conditionally essential nutrient in man. J Am Coll Nutr 1986;5:121-5.
21. Geggel HS, Ament ME, Heckenlively JR, Martin DA, Kopple JD. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med 1985;312:142-6.
22. Airaksinen EM, Paljärvi L, Partanen J, Collan Y, Laakso R, Pentikäinen T. Taurine in normal and diseased human skeletal muscle. Acta Neurol Scand 1990;81:1-7.
23. Pierno S, De Luca A, Camerino C, Huxtable RJ, Camerino DC. Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers. J Pharmacol Exp Ther 1998;286:1183-90.
24. Huxtable R, Bressler R. Effect of taurine on a muscle intracellular membrane. Biochim Biophys Acta 1973;323:573-83.
25. Schaffer SW, Azuma J, Madura JD. Mechanisms underlying taurine-mediated alterations in membrane function. Amino Acids 1995;8:931-46.
26. 3H-taurine in mouse skeletal muscle cells by light and electron microscopic radioautography. Cell Mol Biol (Noisy-legrand) 1993;39:397-404.
27. Pasantes-Morales H, Cruz C. Taurine: a physiological stabilizer of photoreceptor membranes. Prog Clin Biol Res 1985;179:371-81.
28. Banks MA, Porter DW, Martin WG, Castranova V. Effects of in vitro ozone exposure on peroxidative damage, membrane leakage, and taurine content of rat alveolar macrophages. Toxicol Appl Pharmacol 1990;105:55-65.
29. Saransaari P, Oja SS. Mechanisms of ischemia-induced taurine release in mouse hippocampal slices. Brain Res 1998;807:118-24.
30. Neumayer C, Nanobashvili J, Fügl A, Blumer R, Punz A, Prager M, et al. α-Tocopherolpretreatment reduces ischemia/reperfusion injury in rabbit skeletal muscle. Eur Surg 2002;34:90-4.
31. Rácz IB, Illyés G, Sarkadi L, Hamar J. The functional and morphological damage of ischemic reperfused skeletal muscle. Eur Surg Res 1997;29:254-63.
32. Santavirta S, Luoma A, Arstila AU. Ultrastructural changes in striated muscle after experimental tourniquet ischaemia and short reflow. Eur Surg Res 1978;10:415-24.
33. Sternbergh WC, Adelman B. The temporal relationship between endothelial cell dysfunction and skeletal muscle damage after ischemia and reperfusion. J Vasc Surg 1992;16:30-9.
34. Kawasaki S, Sugiyama S, Ishiguro N, Ozawa T, Miura T. Implication of superoxide radicals on ischemia-reperfusion induced skeletal muscle injury in rats. Eur Surg Res 1993;25:129-36.
35. Lee YH, Wei FC, Lee J, Su MS, Chang YC. Effect of postischemic reperfusion on microcirculation and lipid metabolism of skeletal muscle. Microsurgery 1995;16:522-7.